Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dexamethasone sodium phosphate + bupivacaine hydrochloride + isopropyl alcohol + triamcinolone
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Parenteral, Intramuscular, Intraarticular, Intralesional
01
Overview
This entry most plausibly refers to a **multi-ingredient compounded injectable corticosteroid/anesthetic mixture** containing dexamethasone sodium phosphate, triamcinolone, bupivacaine hydrochloride, and isopropyl alcohol. Pharmacologically, dexamethasone sodium phosphate and triamcinolone are synthetic glucocorticoids that suppress inflammatory gene transcription through the glucocorticoid receptor, while bupivacaine hydrochloride is a local anesthetic that blocks voltage-gated sodium channels to provide analgesia. The inclusion of isopropyl alcohol suggests this is not a standard single-entity approved drug product but rather a nonspecific or possibly erroneous formulation string derived from procedure or compounding context. The provided indication text matches labeled corticosteroid indications for dexamethasone/triamcinolone products generally, not a clearly identifiable branded product with this exact four-component composition.
- Other names
- dexamethasone sodium phosphate + bupivacaine hydrochloride + isopropyl alcohol + triamcinolone
02
Targets
GR (Glucocorticoid receptor)Kir (Inward-rectifier potassium channels)NaV (Voltage-gated sodium channels)MR (Mineralocorticoid receptor)KATP channel (ATP-sensitive potassium channel)
Beyond the preview
Go deeper on dexamethasone sodium phosphate + bupivacaine hydrochloride + isopropyl alcohol + triamcinolone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dexamethasone sodium phosphate + bupivacaine hydrochloride + isopropyl alcohol + triamcinolone.